GS

Gopya Sindhusha Kotari

Active Director Director DIN 11528941
DIN 11528941 First appointment Feb 2026 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Feb 2026
Shareholding value β€’β€’β€’β€’ Premium profile

About Gopya Sindhusha Kotari

Data last updated:

Gopya Sindhusha Kotari is a Director at Srizen Pharmaceuticals Private Limited (since 2026). The company operates in Pharma.

DIN 11528941
Primary Designation Director
Industry Pharma
First Appointment 06 Feb 2026

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director06 Feb 20262026Active

Board colleagues of Gopya Sindhusha Kotari

NameDINCompanyDesignation
Rakesh Kasula08871802Srizen Pharmaceuticals Private LimitedManaging Director

Directorship timeline

Open interactive timeline →
Srizen Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Gopya Sindhusha Kotari

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Gopya Sindhusha Kotari

Gopya Sindhusha Kotari currently holds 1 directorship: Srizen Pharmaceuticals Private Limited (Director, since 06 Feb 2026).

Gopya Sindhusha Kotari was first appointed on 06 Feb 2026 as Director at Srizen Pharmaceuticals Private Limited.

The current boards of Gopya Sindhusha Kotari's companies include Rakesh Kasula (Srizen Pharmaceuticals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available